Charcoal has 3 known drug interactions based on U.S. FDA drug labeling data. Of these, 1 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Miglitol, Acarbose, Olanzapine. Patients taking Charcoal should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Contraindicated
- 1
- Moderate
- 2
Contraindicated (1)
- Charcoal + Miglitol— Intestinal adsorbents like charcoal may reduce the effect of miglitol and should not be taken concomitantly.
Moderate (2)
- Charcoal + Acarbose— Charcoal is an intestinal adsorbent that may reduce the effect of Acarbose and should not be taken concomitantly.
- Charcoal + Olanzapine— Activated charcoal reduces the maximum concentration and AUC of oral olanzapine.